Showing results (1631-1640 of 2,739) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|April 21, 2015
MET: a new promising biomarker in non-small-cell lung carcinomaCristina Pérez-Ramírez, Marisa Cañadas-Garre, Enrique Jiménez-Varo, et al.
Pharmacogenomics|September 5, 2025
Pharmacogenomics of buprenorphine - a narrative reviewLakshmi Aravindan, Sanjana Velu, Inesh Sivam, et al.
Pharmacogenomics|July 30, 2016
Pharmacogenetics of tardive dyskinesia: an updated review of the literatureRachel K Lanning, Clement C Zai, Daniel J Müller
Pharmacogenomics|May 14, 2020
PNPT1 and PCGF3 variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide studyGuangyan Mu, Qian Xiang, Zhuo Zhang, et al.
Pharmacogenomics|June 9, 2015
Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibrationPaulo Caleb Junior Lima Santos, Leiliane Rodrigues Marcatto, Nubia Esteban Duarte, et al.
Pharmacogenomics|June 13, 2015
Update on thiopurine pharmacogenetics in inflammatory bowel diseaseRebecca L Roberts, Murray L Barclay
Pharmacogenomics|June 13, 2015
Strategies for implementation of an effective pharmacogenomics program in pharmacy educationU Subrahmanyeswara Rao, Susan L Mayhew, Prema S Rao
Pharmacogenomics|June 27, 2015
Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicityMi-Young Lee, María Apellániz-Ruiz, Inger Johansson, et al.
Pharmacogenomics|July 1, 2015
Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestryAna Alfirevic, Jill Durocher, Anisa Elati, et al.
Pharmacogenomics|July 1, 2015
Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomersDolores Ochoa, Rocío Prieto-Pérez, Manuel Román, et al.
Pageof 274